Dr. Peter Marks announced his resignation from the U.S. Food and Drug Administration (FDA) as Director of CEBR (Center for ...

The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...

The resignation of Peter Marks, long-time director of the US Food and Drug Administration’s (FDA) centre responsible for ...

In this week’s edition of InnovationRx, we look at Trump's massive health agency layoffs, Palantir’s trade secret lawsuit, ...

With the recently announced layoffs of 3,500 FDA staffers and exits of branch directors Patrizia Cavazzoni and Peter Marks, ...

Amid a dramatic reshaping of the federal healthcare apparatus, the FDA has named an acting leader of its Center for Biologics Evaluation and Research. | Amid a dramatic reshaping of the federal ...

Clifford Lane, a 45-year veteran of the NIH and close confidant of Fauci as NIAID deputy director for clinical research, and ...

Lower levels of "bad" LDL cholesterol could mean a lower risk of dementia and Alzheimer's disease, a new study says.

The eyes also might help detect seniors at risk for a common syndrome in which they emerge from surgery in a state of ...

Medical researchers helped tame a worldwide pandemic, but they may be powerless against the financial disease rapidly ...

Novavax, the FDA and the Department of Health and Human Services did not immediately respond to Reuters' requests for comment ...

Thousands of federal workers are out of a job after reduction-in-force notices were sent across HHS on Tuesday, sparking ...